Exploring how MBRRACE-UK's groundbreaking work in maternal mortality surveillance is transforming maternity care in the UK through data-driven insights and confidential enquiries.
Exploring why HER-2/neu, a key oncogene in breast cancer, shows no significant expression in non-Hodgkin's lymphoma and its implications for cancer research.